PULMONARY HYPERTENSION ASSOCIATION NEWS
‘Medicaid is a Lifeline for Many of my Patients’
The Medicaid program is under threat in Congress. The budget bill could end health care benefits for nearly 11 million people. The bill also includes burdensome requirements that could restrict Medicaid eligibility. “[Medicaid] makes the difference between patients having access to care or going without,” says Kassandra Olgers, a PHA advocate and physician assistant at West Virginia University.
Share Your Ideas for the PHA 2026 Conference Theme
Help PHA come up with a theme for PHA 2026 International PH Conference and Scientific Sessions. Your idea could become the official conference theme. Enter by June 25 for a chance to win two free conference registrations, a $50 Amazon gift card, PHA swag and unlimited bragging rights.
Live in the Denver Area? Join Us for 2 Events in 1 Weekend
If you live in the Denver area, mark your calendars for a Pulmonary Hypertension Association weekend of education, empowerment and support on Saturday, Aug. 23, and Sunday, Aug. 24.
PHPN Symposium Registration Opens June 25
Health care professionals: Registration opens Wednesday, June 25, for the PH Professional Network Symposium. PHA’s PHPN Symposium will bring more than 500 health care professionals to Seattle Sept. 18-20.
PHA’s 6-Minute Challenge Raises $7K
More than 100 people participated in PHA’s first virtual fundraiser, the 6-Minute Challenge. Participants committed to at least six minutes of activity each day in May, from walking to chair yoga. Participants chose activities that best suited their needs.
PHA at ATS: Advancing Innovation, Collaboration, Patient-Focused Care
Matt Granato recently represented the Pulmonary Hypertension Association at the American Thoracic Society International Conference. Granato described the conference as a powerful reminder of the momentum PHA is building in PH research, education and patient advocacy.
Fetal Toxicity Remains Risk for Some PH Therapies
The Food and Drug Administration recently eliminated the fetal toxicity risk-mitigation requirement for three pulmonary hypertension medications. FDA removed the Risk Evaluation and Mitigation Strategies requirement for ambrisentan, macitentan and the macitentan-tadalafil combination tablet, but not bosentan.
Share Your Ideas for the PHA 2026 Conference Theme
Help PHA come up with a theme for PHA 2026 International PH Conference and Scientific Sessions on June 11-14, 2026, in Dallas. Your idea could become the official conference theme. Enter by June 25 for a chance to win two free conference registrations, a $50 Amazon gift card, PHA swag and unlimited bragging rights.
PHPN Symposium Registration Opens June 25
Health care professionals: Registration opens Wednesday, June 25, for the PH Professional Network Symposium. PHA’s PHPN Symposium will bring more than 500 health care professionals to Seattle Sept. 18-20.